pediatric ARVs

USAID/TSP HIV Child and Adolescent ARV Procurement Forecasting Tool

The USAID/TSP HIV Child and Adolescent ARV Procurement Forecasting Tool is intended to assist program managers, clinicians and support staff in quantifying and budgeting for a program’s child and adolescent ARV needs. The tool: i) allows the user to insert the number of children and adolescents needing ARVs; and ii) provides an output describing how the children and adolescents are expected to transition into different weight bands over time.

Include in home page features rotation
Off

The Need for Pediatric Formulations to Treat Children with HIV

Is the resource available on the Internet?
Yes
Author
Adrienne F. Schlatter, Andrew R. Deathe and Rachel C. Vreeman

Over 3.2 million children worldwide are infected with HIV, but only 24% of these children receive antiretroviral therapy (ART). ART adherence among children is a crucial part of managing human-immunodeficiency virus (HIV) infection and extending the life and health of infected children. Important causes of poor adherence are formulation- and regimen-specific properties, including poor palatability, large pill burden, short dosing intervals, and the complex storage and transportation of drugs.

Include in home page features rotation
Off
Subscribe to pediatric ARVs